A new urine test could identify people with bladder cancer more accurately than current diagnostic methods, researchers found ...

Bladder cancer is the 9th most common cause of cancer death in the UK, with around 5,900 deaths every year; that’s 16 every day (2022-2024). Each year almost three-quarters (73%) of bladder cancer ...

Researchers developed a urine test that detects bladder cancer, predicts which patients will benefit from immunotherapy ...

TAR-200 monotherapy shows highest complete response with sustained benefits in 12-month data from Phase 2b SunRISe-1 study (Cohort 2) Compelling first results from Cohort 4 of Phase 2b SunRISe-1 study ...

Age can affect bladder cancer survival, with older age typically linking to reduced survival rates. Other factors impacting bladder cancer survival can include the cancer’s stage. Bladder cancer ...

A simple urine test devised by researchers at Stanford Medicine and the VA Palo Alto Health Care System can diagnose people ...

A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with high-risk non-muscle-invasive bladder cancer whose cancer had previously ...

Bladder cancer frequently announces itself through symptoms that patients dismiss as minor urinary issues, and that delay between first sign and diagnosis can mean the difference between a ...

India, a country rich in culture and brimming with potential, has citizens who work very hard to make ends meet and lead a prosperous life. However, amidst the hustle, a silent yet severe health issue ...